Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis. Nyirjesy P, Schwebke JR, Angulo DA, Harriott IA, et al. Clin Infect Dis 2022;74:2129-2135.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nyirjesy P, Schwebke JR, Angulo DA, Harriott IA, et al. Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis. Clin Infect Dis 2022;74:2129-2135.
PMID: 34555149